Stage III Non-Small Cell Lung Cancer AJCC v7 Active Not Recruiting Phase 2 Trials for Cediranib (DB04849)

Also known as: Stage III Lung Non-Small Cell Cancer AJCC v7

IndicationStatusPhase
DBCOND0090379 (Stage III Non-Small Cell Lung Cancer AJCC v7)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02498613A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid TumorsTreatment